The Angiogenesis Foundation
Juliana Figueiredo, MS, RDN, LDN is a Chief of Staff at The Angiogenesis Foundation with previous experience as a Research Assistant and Teaching Assistant at The Friedman School of Nutrition Science and Policy at Tufts University. Juliana also worked as a Laboratory Assistant at the Jean Mayer USDA Human Nutrition Research Center on Aging and gained experience as a Dietetics and Nutrition Intern at Memorial Healthcare System, Cleveland Clinic Flor, and Meals on Wheels America. Juliana also has a background in business management, having owned and managed Saas Store in Brazil. Juliana holds a Master's of Science in Biochemical & Molecular Nutrition from The Friedman School of Nutrition Science and Policy at Tufts University.
This person is not in any teams
This person is not in any offices
The Angiogenesis Foundation
Founded in 1994, the Angiogenesis Foundation is the world’s first 501(c)(3) nonprofit organization dedicated to conquering disease using a new approach based on angiogenesis, the growth of new capillary blood vessels in the body. We have identified angiogenesis as the “common denominator” in society’s most feared diseases. Our focus on this underlying process of many different diseases makes our approach as a medical organization unique. The Foundation is the recognized, expert voice and champion of this new field of medicine. Based in Cambridge, Massachusetts, the Angiogenesis Foundation’s goal is to help people lead healthier, longer lives by restoring balance to blood vessel growth. Through research, education, and advocacy — with patients, physicians, researchers, industry, payers, and government — we enable patients to gain access to safe and effective treatments coming from the angiogenesis field for cancer, blinding diseases, wounds, and many other serious diseases. As a scientific organization, the Angiogenesis Foundation is independent of any individual, institution, or commercial entity. We are committed to helping people around the world benefit from the full promise of angiogenesis-based medicine, and to make life-, limb-, and vision-saving treatments available to everyone in need.